Vertiseit AB Series B (VERT-B) fair value: what the stock is really worth
As of Oct 2, 2026: fair value of Vertiseit AB Series B SEK 7.71, price SEK 63.40, upside -87.8%, quality 28 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Vertiseit AB Series B for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
Vertiseit AB (publ) operates as a retail tech platform company in Sweden and the rest of the European Union. It operates in three segments: Software as a Service (SaaS), Consulting, and Systems segments. The company offers in-store experience management (IXM) SaaS platforms for brands and retailers.
Show more
Vertiseit AB (publ) operates as a retail tech platform company in Sweden and the rest of the European Union. It operates in three segments: Software as a Service (SaaS), Consulting, and Systems segments. The company offers in-store experience management (IXM) SaaS platforms for brands and retailers. It also provides digital displays, media players, sensors, and other technical equipment; consulting services, including strategy, concept development, project management, design and development, and system integration; and licensing, monitoring, and support services for its platform. Vertiseit AB (publ) was incorporated in 2008 and is headquartered in Varberg, Sweden.
Stock analysis
Vertiseit AB Series B (VERT-B) currently trades at kr 63.40, while our model-based Fair Value estimate is kr 7.71, 87.8% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Asset-Based group reads highest at a median of kr 15.55 per share, and 0 of the 21 models we run sit above the kr 63.40 price.
Bear case: the Multiples group reads lowest at kr 3.29, and 21 of the 21 models stay below the price. Evidence for this calculation is low.
Scenario range: kr 4.06 (bear) to kr 12.71 (bull), the price of kr 63.40 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 28/100 (below-average quality), in the Technology sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Vertiseit AB Series B reported revenue of 676M SEK in FY2025 versus 131M SEK in FY2021, a compound +50.8%/yr. Reported net income was 6.0M SEK in FY2025, compounding +25.2%/yr from FY2021. FY2021 was a trough year, so the rate overstates the trend.
Key figures
Market cap 2.1B SEK (≈ $212M) · P/S ratio 2.95 · EPS (TTM) kr 0.0400 · Net margin 0.9% · Return on equity 0.3% · Return on assets (EBIT) 3.0% · Operating margin 4.4% · Revenue (TTM) 670M SEK.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 40 out of 100 (medium confidence).
What moves the price
The share trades about 13% below its 52-week high and 36% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Technology peers we cover trades at 44% fair-value upside, at −88%, VERT-B screens richer than that median.
Fair Value models
The price assumes far more growth than our models allow for, so the models scatter widely (kr 2.31 to kr 43.07). Read the Fair Value as a cautious anchor, not a price target; the Growth Forecast section shows what the price assumes.
Bear kr 4.06Fair Value kr 7.71Bull kr 12.71
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (kr 0.0302 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.85/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+45.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+29.0%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+54.5%
Start year 2020 (pandemic). Over 10 years: +31.8% a year
Revenue growth 13 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+38.3%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−11.8%
Earnings growth per share plus dividend.
Earnings per share, growth per year−11.8%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−11.8% vs −22.0%, picking up
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.9% → 3%
Start year 2020 (pandemic)
⚠ Revenue per share shrinking 10.8%/yr over ~10Y (margins eroding too) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
Growth Forecast
A lot of optimism in the price
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
more than +80 %
Yearly growth needed for the next five years to justify today's price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Information Technology Services · 463 stocks
Beats the industry median on 2/11 measures
Overall it trails its industry peers.
Valuation
Quality Score28 · Bottom 25%
Fair Value upside−87.8% · Bottom 25%
Profitability
Return on equity (TTM)0.3% · Below median
Return on assets1.3% · Below median
Net margin (TTM)0.3% · Below median
Operating margin (TTM)4.4% · Below median
Growth and dividend
Revenue growth−3.5% · Below median
Balance sheet
Debt / equity0.28× · Above median
Valuation Multiplesvs Information Technology Services median · lower = cheaper
P/B0.29× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
P/S (TTM)0.32× · Cheapest 25%
P/FCF62.3× · Priciest 25%
EV/EBITDA6.9× · Cheaper than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 43
FUTURE (revenue growth)0· sector 29
PAST (return on equity)1· sector 35
HEALTH (low debt)86· sector 97
DIVIDEND (yield)0· sector 43
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Vertiseit AB Series B Fair Value". https://www.fairvalue-calculator.com/stock/VERT-B
Frequently asked questions
Is Vertiseit AB Series B (VERT-B) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of kr 7.71 versus a price of kr 63.40, about −88% upside (overvalued).
What is the fair value of VERT-B?
Our model-based fair value for Vertiseit AB Series B is kr 7.71 (as of Sep 24, 2026), built from audited fundamentals. The current price: kr 63.40.
What is the quality score of VERT-B?
Vertiseit AB Series B has a Quality Score of 28/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Vertiseit AB Series B (VERT-B)?
Our model-based price target is the fair value of kr 7.71 (as of Sep 24, 2026) from 21 valuation models. Cautious scenario kr 4.06, optimistic scenario kr 12.71. It is a calculation from audited fundamentals, not an analyst target.
What is the Vertiseit AB Series B stock forecast for 2026?
Our models put fair value at kr 7.71, about −88% upside versus a price of kr 63.40 (overvalued). Cautious scenario kr 4.06, optimistic scenario kr 12.71. The calculation is refreshed regularly with new filings.
What is the revenue of Vertiseit AB Series B (VERT-B)?
Vertiseit AB Series B reported trailing-twelve-month revenue of about 670M SEK (latest available figure, as of Sep 24, 2026).
What growth is priced into Vertiseit AB Series B (VERT-B)?
For today's price to be fair in a discounted-cash-flow model, Vertiseit AB Series B would have to grow free cash flow by more than 80 % per year for five years (discount rate 11.0 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +54.5 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of VERT-B use?
Our models discount Vertiseit AB Series B at 11.0 %: a base by market capitalisation (micro), damped by beta 0.53, country premium for Sweden. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Vertiseit AB Series B that is more than 80 % per year a year over ten years, using the same discount rate (11.0 %) and the same formula as our fair value.
How much growth has Vertiseit AB Series B (VERT-B) delivered so far?
Over the past 5 years revenue at Vertiseit AB Series B grew +54.5 % a year. The price currently implies more than 80 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Vertiseit AB Series B (VERT-B) growing?
The median revenue growth in the sector is +10.3 % a year. That is the yardstick for the growth priced into Vertiseit AB Series B (more than 80 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Vertiseit AB Series B (VERT-B)?
The free-cash-flow yield on the price is 0.16 %: that much free cash flow Vertiseit AB Series B produces per unit of market value. When it exceeds the discount rate of our models (11.0 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Vertiseit AB Series B (VERT-B)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Vertiseit AB Series B it is kr 7.71 per share (as of Sep 24, 2026), against a price of kr 63.40. It is the blended result of 21 valuation models (cash flow, earnings, asset, dividend).
Is Vertiseit AB Series B stock overvalued or undervalued in 2026?
As of Sep 24, 2026, VERT-B trades above its calculated fair value: price kr 63.40, fair value kr 7.71, a gap of about −88% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of VERT-B?
No. The price is what the market pays today (kr 63.40); the fair value is what the company's own numbers justify (kr 7.71). For Vertiseit AB Series B the two are kr 55.69 per share apart. That gap is exactly why we show both numbers side by side.
How much is Vertiseit AB Series B worth?
The market values Vertiseit AB Series B at about 2.1B SEK (market capitalisation, as of Sep 24, 2026). Per share that is kr 63.40; our models calculate a fair value of kr 7.71 per share.
What do the bullish and bearish scenarios say about VERT-B?
Our models span a range for Vertiseit AB Series B: cautious scenario kr 4.06, base kr 7.71, optimistic kr 12.71 per share (as of Sep 24, 2026, price kr 63.40). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Vertiseit AB Series B (VERT-B)?
Balance-sheet figures for Vertiseit AB Series B (as of Sep 24, 2026): return on equity 0.3%, debt of 0.28 per unit of equity. They feed the Quality Score of 28/100, which measures business quality independently of the share price.
How far is VERT-B from its 52-week high?
Vertiseit AB Series B trades at kr 63.40, about 13% below its 52-week high of kr 72.60 and 36% above the low of kr 46.70 (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of kr 7.71 is for.
Which stocks are comparable to Vertiseit AB Series B?
From the same area (Technology) we also value International Business Machines Corporation, Accenture plc, Tata Consultancy Services Limited, Infosys Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Vertiseit AB Series B stock attractive at the current price?
The data as of Sep 24, 2026: price kr 63.40, calculated fair value kr 7.71 (−88%), Quality Score 28/100, from 21 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of VERT-B calculated?
We run Vertiseit AB Series B through 21 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of kr 7.71, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Vertiseit AB Series B itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Vertiseit AB Series B (VERT-B)?
The closing price on Oct 2, 2026 was kr 63.40. Our model-based fair value is kr 7.71, about −88% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Vertiseit AB Series B right now?
The price sits above even our optimistic bull case (kr 12.71). The favourable scenario is already priced in. Weak quality (28/100) and above fair value at the same time, the margin of safety is missing on both counts. The model range is unusually wide (kr 4.06 to kr 12.71). The outcome hinges heavily on assumptions, so read the point estimate with caution. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Where does the earnings growth of Vertiseit AB Series B (VERT-B) come from?
Earnings per share at Vertiseit AB Series B grew +5.9 % a year from 2014 to 2025. Broken into its drivers: revenue per share +8.7 %, EBIT margin −2.9 %, tax rate +1.4 %, residual (interest, one-offs) −1.1 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Vertiseit AB Series B
How large is the market capitalisation of Vertiseit AB Series B (VERT-B)?
The market capitalisation of Vertiseit AB Series B is 2.1B SEK (≈ $212M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Vertiseit AB Series B (VERT-B)?
The price-to-sales ratio of Vertiseit AB Series B is 2.95 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Vertiseit AB Series B (VERT-B)?
Earnings per share at Vertiseit AB Series B are kr 0.0400. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Vertiseit AB Series B (VERT-B)?
The net margin of Vertiseit AB Series B is 0.9% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Vertiseit AB Series B (VERT-B)?
The return on equity (ROE) of Vertiseit AB Series B is 0.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Vertiseit AB Series B (VERT-B)?
On an EBIT basis the return on assets of Vertiseit AB Series B is 3.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Vertiseit AB Series B (VERT-B)?
The operating margin of Vertiseit AB Series B is 4.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Vertiseit AB Series B (VERT-B)?
Revenue at Vertiseit AB Series B is growing −3.5% versus a year earlier (3y avg +29.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Vertiseit AB Series B (VERT-B)?
Earnings per share at Vertiseit AB Series B are growing −70.6% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Vertiseit AB Series B (VERT-B) carry?
The net debt of Vertiseit AB Series B is 285M SEK (fiscal year 2025, ≈ 83.7 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Vertiseit AB Series B in the live analysis
One click puts Vertiseit AB Series B on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
